gavreto
roche registration gmbh - pralsetinib - Карцином, недребноклетъчен белодроб - Антинеопластични средства - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.
klimodien 2 mg/2 mg coated tablets
bayer schering pharma ag - Естрадиол Диеногест - 2 mg/2 mg coated tablets
eloine 0,02 mg/3 mg film - coated tablets
bayer schering pharma ag - Этинилэстрадиол, drospirenon - 0,02 mg/3 mg film - coated tablets
gadovist 1,0 mmol/ml solution for injection pre - filled sirynge/cartridge
bayer schering pharma ag - Гадобутрол - 1,0 mmol/ml solution for injection pre - filled sirynge/cartridge
berinert 1500 1500 iu powder and solvent for solution for injection or infusion/infusion
csl behring gmbh - С1-инхибитор - 1500 iu powder and solvent for solution for injection or infusion/infusion
alubrex 5,50 g/1 solution for infusion
csl behring gmbh - Албумин - 5,50 g/1 solution for infusion
alubrex 20 200 g/1 solution for infusion
csl behring gmbh - Албумин - 200 g/1 solution for infusion
beriate 250 iu powder and solvent for solution for injection or infusion
csl behring gmbh - Коагулационен фактор viii - 250 iu powder and solvent for solution for injection or infusion
beriate 500 iu powder and solvent for solution for injection or infusion
csl behring gmbh - Коагулационен фактор viii - 500 iu powder and solvent for solution for injection or infusion
beriate 1000 iu powder and solvent for solution for injection or infusion
csl behring gmbh - Коагулационен фактор viii - 1000 iu powder and solvent for solution for injection or infusion